Aurinia Pharmaceuticals Inc (AUPH)
CapEx to Revenue
0.00%
Quarterly · Period ending:
AUPH CapEx to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
AUPH Quarterly CapEx/Revenue (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
AUPH capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 0.0002% | |
| 0.0502% | |
| 0.0905% | |
| 0.0885% | |
| 0.14% | |
| 0.0272% | |
| 0.0935% | |
| 0.1254% | |
| 0.2238% | |
| 0.0239% | |
| 0.1308% | |
| 0.1926% | |
| 0.5471% | |
| 1.4793% | |
| 0.4713% | |
| 0.0675% | |
| 0.1383% | |
| 0.3653% | |
| 0.1495% | |
| 1.0841% | |
| 3.4441% | |
| 129.2123% | |
| 8.9326% | |
| 14,755.1724% | |
| 451.7241% | |
| 710% | |
| 96.5517% | |
| 13.0435% | |
| 75.8621% | |
| 66.6667% | |
| 75.8621% | |
| 0% | |
| 106.8966% | |
| 73.3333% | |
| 29.0323% | |
| 0% | |
| 3.6474% | |
| 12.9032% | |
| 56.6667% | |
| 12.9032% | |
| 5.4545% | |
| 1.7544% | |
| 0% | |
| 31.5789% | |
| 37.2881% | |
| 16.129% | |
| 30.8824% | |
| 29.1667% | |
| 66.1972% | |
| 1.4925% | |
| 2.4548% | |
| 42.5291% | |
| 55.1724% | |
| 6.7416% | |
| 11.2968% | |
| 12.7907% | |
| 10.0001% | |
| 0.1552% | |
| 70.865% | |
| 0.0386% | |
| 18.7144% | |
| 791.0496% | |
| 7.0597% | |
| 10.5897% | |
| 1.3012% | |
| 1.2195% | |
| 4.0704% | |
| 10.8723% | |
| 4.4991% | |
| 5.0184% | |
| 104.7643% | |
| 2.1539% | |
| 18.5653% | |
| 13.8169% | |
| 47.2624% | |
| 47.7023% | |
| 27.4182% | |
| 32.0458% | |
| 53.6415% | |
| 113.6737% | |
| 6.4917% | |
| 16.6667% | |
| -54.2334% | |
| 0.7545% | |
| 23.6603% | |
| 17.4479% | |
| 47.2931% | |
| 192.898% | |
| 36.0844% | |
| 32.3002% | |
| 33.7823% | |
| 173.5212% | |
| 12.3812% | |
| 329.3382% | |
| 440.6081% | |
| 31.2029% | |
| 5.6106% | |
| 76.6012% | |
| 76.584% | |
| 26.5159% |